Cancer mortality has improved due to earlier detection via screening, as well as due to novel
cancer therapies such as tyrosine kinase inhibitors and immune checkpoint inhibitions …

Abstract Purpose of Review Successful treatment of cancer can be hampered by the
attendant risk of cardiotoxicity, manifesting as cardiomyopathy, left ventricle systolic …

Novel therapeutic options have significantly improved survival and long-term outcomes in
many cancer entities. Unfortunately, this improvement in outcome is often accompanied by …

Cardiotoxicity may present as (pulmonary) hypertension, acute and chronic coronary
syndromes, venous thromboembolism, cardiomyopathies/heart failure, arrhythmia, valvular …

A new type of hybrid polymer particles capable of carrying the cytostatic drug doxorubicin
and labeled with a gallium compound was prepared. These microparticles consist of a core …

Injuries related to articular cartilage are among the most challenging musculoskeletal
problems because of poor repair capacity of this tissue. The lack of efficient treatments for …

Aim: The authors aimed to develop Dox@ Rg1 nanoparticles with decreased cardiotoxicity
to expand their application in cancer. Materials & methods: Dox@ Rg1 nanoparticles were …

Aim This study aimed to investigate the potential protective effects of N‐acetyl‐L‐cysteine
(NAC) against apical periodontitis (AP) in rats with adriamycin (ADR)‐induced kidney and …

Overproduction of reactive oxygen species (ROS) is a well-established indicator of ongoing
tissue inflammation. However, there is a scarcity of molecular imaging probes capable of …

Mitochondrial dysfunction plays a key role in doxorubicin-induced cardiotoxicity (DIC). In this
proof-of-principle study, we investigated whether PET mapping of cardiac membrane …